Medical News

RSS

NIH funding supports development of AI tools to prevent HIV, hepatitis C and overdose

Natasha Martin, DPhil, professor and vice chief of Global Public Health in the Division of Infectious Diseases and Global Public Health at UC San Diego School of Medicine, has been awarded a five-year, $5.6 million Avant-Garde Award from the National Institute on Drug Abuse (NIDA), one of the most prestigious and competitive NIH research awards.

23 Jun 2026

Artificial intelligence helps breast cancer patients avoid unnecessary chemotherapy

Research led by RCSI University of Medicine and Health Sciences and University College Dublin (UCD) has identified immune markers that could help doctors more accurately determine which breast cancer patients are unlikely to benefit from chemotherapy, potentially sparing some patients from unnecessary treatment.

23 Jun 2026

Researchers identify control switch protein that starves tuberculosis bacteria

A protein that acts as a 'control switch,' preventing Mycobacterium tuberculosis from accessing the energy sources it needs to survive, has been identified by researchers at the University of Surrey.

23 Jun 2026

Synthetic protein hybrid offers promising treatment for liver diseases

The research group led by CIC biomaGUNE's Ikerbasque Research Professor Aitziber L. Cortajarena has developed an innovative anti-fibrotic and anti-tumor treatment by binding a synthetic protein to gold nanoclusters (small aggregates of approximately 6 atoms of gold).

23 Jun 2026

New project aims to systematically map billion cellular interactions

...

23 Jun 2026

Curtin University projects explore youth health issues in Western Australia

Curtin University Curtin University researchers will examine the 'partygoing' behaviours of young people in regional areas, the use of nicotine pouches and ways to promote physical activity among young people as part of new projects funded by Healthway.

23 Jun 2026

New TRUECAM wrapper makes medical artificial intelligence more trustworthy

Medical artificial intelligence (AI) faces a fundamental challenge: uncertainty quantification. Artificial neural networks are largely unaware of the limits of their training data and can become overconfident when confronted with unfamiliar inputs. Suppose you train a neural network to distinguish among African mammals.

23 Jun 2026

Stockholm3 blood test may offer more accurate prostate cancer detection

...

23 Jun 2026

Revolutionary protective shoe concept provides increased comfort and minimizes strain

A revolutionary protective shoe concept adapts to the needs of users in a new way and provides increased comfort and minimizes strain.

23 Jun 2026

TRIMTECH Therapeutics brings total seed round to $47 M with additional investment of $14 M to further develop TRIMTAC and TRIMGLUE targeted protein degradation portfolio

TRIMTECH Therapeutics, a biotechnology company developing novel small molecule therapies that target and degrade protein aggregates associated with neurodegenerative diseases, today announced it has raised an additional $14 million in seed funding, bringing the total for the round to $47 million (£35 million).

From TRIMTECH Therapeutics 23 Jun 2026

The menstrual cycle changes heart-rate variability but not strength

Menstrual cycle phases influence heart autonomic regulation, showing HRV variations, yet muscle performance and mood states remain largely unchanged.

23 Jun 2026

Longer breastfeeding links to fewer ADHD symptoms in children

Longer durations of full breastfeeding are linked to fewer ADHD symptoms in children, suggesting early feeding patterns may influence neurodevelopment.

23 Jun 2026

Elite athletes with higher vitamin D show healthier lipid profiles

Higher serum 25-hydroxyvitamin D levels were independently associated with lower LDL-C, triglycerides, and lipoprotein(a) in 773 male professional athletes. The cross-sectional study cannot establish causality, but it suggests that vitamin D status may be linked to cardiovascular risk-related lipid markers, even in elite athletic populations.

23 Jun 2026

Trial identifies 4 grams a day as the tested safe level for L-tyrosine in healthy men

A randomized, crossover trial in healthy adult men found that 4 weeks of L-tyrosine supplementation at doses up to 4 g/day did not cause clinically meaningful changes in safety markers, diet, blood pressure, or body measures. The highest tested dose, 4 g/day, was identified as the no-observed-adverse-effect level under the study’s four-week conditions, although broader and longer-term studies are still needed.

23 Jun 2026

50-year review shows global Ebola spread remains rare despite outbreak fears

Researchers reviewed Ebola disease cases outside Africa from 1976 to May 2026 and found only 28 confirmed epidemic-linked cases, most involving medical evacuation or occupational exposure. Only four latent travelers were diagnosed after border screening, suggesting that undetected intercontinental spread remains rare when outbreaks are controlled at source.

23 Jun 2026

Andes virus cases on MV Hondius highlight hidden risks of confined travel

A Eurosurveillance report describes a multi-country response to an Andes virus outbreak linked to the Dutch-flagged expedition cruise ship MV Hondius, with 13 cases and three deaths reported as of June 18, 2026. Investigators found evidence consistent with an initial zoonotic infection before embarkation, followed by likely person-to-person transmission among passengers and crew in a confined ship setting.

23 Jun 2026

Insilico and SK Biopharmaceuticals partner to develop AI-driven neuroimmune therapies

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and SK Biopharmaceuticals, a Korean-based company leads the way in biotech innovation with groundbreaking drug research, development, and commercialization worldwide, announced a research and development collaboration at the BIO 2026 International Convention to discover AI-enabled innovative drug candidates in the neuroimmune area of the central nervous system.

22 Jun 2026